NO20071271L - Aryl-substituerte polyakryliske aminer, fremgangsmate for fremstilling av disse og anvendelse som et medikament. - Google Patents

Aryl-substituerte polyakryliske aminer, fremgangsmate for fremstilling av disse og anvendelse som et medikament.

Info

Publication number: NO20071271L
Authority: NO; Norway
Prior art keywords: aryl; medicament; processes; preparation; amines
Prior art date: 2004-08-16

Application number

NO20071271A

Other languages

English (en)

Norwegian (no)

Inventor

Matthias Gossel

Lothar Schwink

Siegfried Stengelin

Gerhard Hessler

Petra Lennig

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-16

Filing date

2007-03-08

Publication date

2007-03-16

2007-03-08 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2007-03-16 Publication of NO20071271L publication Critical patent/NO20071271L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Indole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO20071271A 2004-08-16 2007-03-08 Aryl-substituerte polyakryliske aminer, fremgangsmate for fremstilling av disse og anvendelse som et medikament. NO20071271L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004039789A DE102004039789A1 (de)	2004-08-16	2004-08-16	Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP2005/008889 WO2006018280A2 (de)	2004-08-16	2005-08-16	Arylsubstituierte polycycliche amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number	Publication Date
NO20071271L true NO20071271L (no)	2007-03-16

Family

ID=35610053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20071271A NO20071271L (no)	2004-08-16	2007-03-08	Aryl-substituerte polyakryliske aminer, fremgangsmate for fremstilling av disse og anvendelse som et medikament.

Country Status (28)

Country	Link
US (5)	US7838547B2 (sl)
EP (2)	EP1781656B1 (sl)
JP (2)	JP2008509957A (sl)
KR (2)	KR20070053225A (sl)
CN (2)	CN101006091B (sl)
AR (2)	AR050604A1 (sl)
AT (1)	ATE381564T1 (sl)
AU (2)	AU2005274315A1 (sl)
BR (2)	BRPI0514404A (sl)
CA (2)	CA2577255A1 (sl)
CY (1)	CY1108077T1 (sl)
DE (2)	DE102004039789A1 (sl)
DK (1)	DK1781656T3 (sl)
ES (1)	ES2297758T3 (sl)
IL (2)	IL181008A0 (sl)
MA (1)	MA28795B1 (sl)
MX (2)	MX2007001478A (sl)
MY (1)	MY145133A (sl)
NO (1)	NO20071271L (sl)
PE (2)	PE20060626A1 (sl)
PL (1)	PL1781656T3 (sl)
PT (1)	PT1781656E (sl)
RU (1)	RU2007109600A (sl)
SI (1)	SI1781656T1 (sl)
TW (2)	TW200621780A (sl)
UY (2)	UY29072A1 (sl)
WO (2)	WO2006018280A2 (sl)
ZA (1)	ZA200700354B (sl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004039789A1 (de) *	2004-08-16	2006-03-02	Sanofi-Aventis Deutschland Gmbh	Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2006038680A1 (ja) *	2004-10-01	2006-04-13	Banyu Pharmaceutical Co.,Ltd	２－アリールカルボキサミド－含窒素複素環化合物
US7855289B2 (en)	2005-08-04	2010-12-21	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US8088928B2 (en)	2005-08-04	2012-01-03	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US8093401B2 (en)	2005-08-04	2012-01-10	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US7728031B2 (en) *	2006-02-24	2010-06-01	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole derivatives
KR20090004976A (ko) *	2006-04-19	2009-01-12	아스테라스 세이야쿠 가부시키가이샤	아졸카르복사미드 유도체
DE102006021874B4 (de) *	2006-05-11	2008-03-27	Sanofi-Aventis	4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
MX2009001043A (es)	2006-08-08	2009-02-06	Sanofi Aventis	Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para preparalas, medicamentos que comprenden estos compuestos y su uso.
PL2076508T3 (pl)	2006-10-18	2011-05-31	Pfizer Prod Inc	Związki biaryloeteru mocznika
WO2008068265A1 (en) *	2006-12-05	2008-06-12	Janssen Pharmaceutica N.V.	Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases
JP5390404B2 (ja) *	2007-02-16	2014-01-15	エミスフェアー・テクノロジーズ・インク	活性薬剤を送達するための環状部分を有する化合物及び組成物
US8173683B2 (en)	2007-03-06	2012-05-08	Allergan, Inc.	Methods for treating cognitive disorders
NZ580266A (en)	2007-04-27	2012-03-30	Purdue Pharma Lp	Trpv1 inhibitors / antagonists and uses thereof
CL2008001822A1 (es) *	2007-06-20	2009-03-13	Sirtris Pharmaceuticals Inc	Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
EP2188288A1 (en)	2007-09-11	2010-05-26	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
MX2010004499A (es)	2007-10-24	2010-05-20	Astellas Pharma Inc	Compuesto de azolcarboxamida o sal de el.
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
BRPI0917785B1 (pt) *	2008-08-22	2020-08-04	Saudi Aramco Technologies Company	Catalisadores e métodos para a síntese de polímeros
CN102282132A (zh) *	2008-11-19	2011-12-14	先灵公司	二酰基甘油酰基转移酶的抑制剂
US8691865B2 (en)	2008-11-26	2014-04-08	Abbvie Inc.	Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
CN102292319A (zh) *	2008-11-26	2011-12-21	雅培制药有限公司	作为钙通道阻滞剂的取代八氢环戊二烯并(c)吡咯-4-胺
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
CN102388054B (zh)	2008-12-19	2015-03-04	西特里斯药业公司	噻唑并吡啶沉默调节蛋白调节剂的化合物
CA2771278A1 (en)	2009-08-26	2011-03-03	Sanofi	Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
US9452980B2 (en)	2009-12-22	2016-09-27	Hoffmann-La Roche Inc.	Substituted benzamides
US8796470B2 (en)	2010-05-25	2014-08-05	Abbvie Inc.	Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators
CN104860907A (zh)	2010-06-07	2015-08-26	诺沃梅迪科斯有限公司	呋喃基化合物及其用途
US8980924B2 (en)	2010-11-24	2015-03-17	The Trustees Of Columbia University In The City Of New York	Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease
US8828995B2 (en)	2011-03-08	2014-09-09	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120054A1 (de)	2011-03-08	2012-09-13	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120055A1 (de)	2011-03-08	2012-09-13	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2766349B1 (de)	2011-03-08	2016-06-01	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
KR20150055094A (ko)	2011-06-22	2015-05-20	퍼듀 퍼머 엘피	디히드록시 치환기를 포함하는 trpv1 길항제 및 그의 용도
HUE048706T2 (hu)	2013-10-14	2020-08-28	Eisai R&D Man Co Ltd	Szelektíven szubsztituált kinolin-vegyületek
ES2670550T3 (es)	2013-10-14	2018-05-30	Eisai R&D Management Co., Ltd.	Derivados de quinolina selectivamente sustituidos
WO2015188085A1 (en)	2014-06-06	2015-12-10	Flexus Biosciences, Inc.	Immunoregulatory agents
JO3589B1 (ar)	2014-08-06	2020-07-05	Novartis Ag	مثبطات كيناز البروتين c وطرق استخداماتها
UY36391A (es)	2014-11-05	2016-06-01	Flexus Biosciences Inc	Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
EA201790806A1 (ru)	2014-11-05	2017-11-30	Флексус Байосайенсиз, Инк.	Иммунорегулирующие средства
UY36390A (es)	2014-11-05	2016-06-01	Flexus Biosciences Inc	Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
SG11201807516UA (en)	2016-03-17	2018-09-27	Hoffmann La Roche	5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar
LT3448859T (lt)	2017-03-20	2019-10-25	Forma Therapeutics Inc	Pirolpirolo kompozicijos, kaip piruvato kinazės (pkr) aktyvatoriai
US11299481B2 (en)	2017-10-20	2022-04-12	Vanderbilt University	Antagonists of the muscarinic acetylcholine receptor M4
JP2021503443A (ja) *	2017-10-31	2021-02-12	ヴァンダービルトユニバーシティー	ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト
KR20200116945A (ko)	2018-02-02	2020-10-13	반더빌트유니버시티	무스카린성 아세틸콜린 수용체 m4의 길항제
US11001588B2 (en)	2018-09-19	2021-05-11	Forma Therapeutics, Inc.	Activating pyruvate kinase R and mutants thereof
US12053458B2 (en)	2018-09-19	2024-08-06	Novo Nordisk Health Care Ag	Treating sickle cell disease with a pyruvate kinase R activating compound
AU2020349555A1 (en)	2019-09-19	2022-04-07	Forma Therapeutics, Inc.	Activating Pyruvate Kinase R
US12128035B2 (en)	2021-03-19	2024-10-29	Novo Nordisk Health Care Ag	Activating pyruvate kinase R
CN113845427B (zh) *	2021-09-07	2024-06-25	华东师范大学	芳基醇、芳基酮、芳基羧酸化合物及其合成方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9314973D0 (en)	1993-07-20	1993-09-01	Smithkline Beecham Plc	Medicaments
DE50008597D1 (de)	1999-03-08	2004-12-16	Bayer Healthcare Ag	Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
CA2386474A1 (en)	1999-09-20	2001-03-29	Takeda Chemical Industries, Ltd.	Melanin concentrating hormone antagonist
CA2389681C (en) *	1999-11-26	2010-11-02	Shionogi & Co., Ltd.	Npy y5 antagonist
EP1257550B1 (en) *	2000-02-04	2005-11-16	Portola Pharmaceuticals, Inc.	Platelet adp receptor inhibitors
CA2384358A1 (en)	2000-07-05	2002-01-10	Synaptic Pharmaceutical Corporation	Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
AU783403B2 (en)	2000-07-05	2005-10-20	H. Lundbeck A/S	Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
EA200300064A1 (ru) *	2000-07-31	2003-06-26	Смитклайн Бичем Пи-Эл-Си	Карбоксамидные соединения и их применение в качестве антагонистов 11cby-рецептора человека
US20030022891A1 (en)	2000-12-01	2003-01-30	Anandan Palani	MCH antagonists and their use in the treatment of obesity
WO2002083628A1 (en) *	2001-04-13	2002-10-24	Boehringer Ingelheim Pharmaceuticals, Inc.	1,4-disubstituted benzo-fused compounds
AU2002305323A1 (en)	2001-05-04	2002-11-18	Tularik Inc.	Fused heterocyclic compounds
DE10139416A1 (de) *	2001-08-17	2003-03-06	Aventis Pharma Gmbh	Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
SK2242004A3 (en)	2001-10-25	2004-11-03	Takeda Chemical Industries Ltd	Quinoline compound
JP2005519876A (ja) *	2001-11-27	2005-07-07	メルク　エンド　カムパニー　インコーポレーテッド	２−アミノキノリン化合物
AU2003226927A1 (en)	2002-04-09	2003-10-27	7Tm Pharma A/S	Novel carboxamide compounds for use in mch receptor related disorders
AU2003222648A1 (en)	2002-05-13	2003-12-02	Eli Lilly And Company	Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
DE10238865A1 (de) *	2002-08-24	2004-03-11	Boehringer Ingelheim International Gmbh	Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
TW200510311A (en) *	2002-12-23	2005-03-16	Millennium Pharm Inc	CCr8 inhibitors
GB0320244D0 (en) *	2003-05-06	2003-10-01	Aventis Pharma Inc	Pyrazoles as inhibitors of tumour necrosis factor
RU2347777C2 (ru) *	2003-07-03	2009-02-27	Ф.Хоффманн-Ля Рош Аг	Двойные агонисты nk1/nk3 для лечения шизофрении
DE10352979A1 (de) *	2003-11-13	2005-06-09	Merck Patent Gmbh	Pyridopyrimidinone
DE102004039789A1 (de)	2004-08-16	2006-03-02	Sanofi-Aventis Deutschland Gmbh	Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

2004
- 2004-08-16 DE DE102004039789A patent/DE102004039789A1/de not_active Withdrawn
2005
- 2005-08-12 AR ARP050103404A patent/AR050604A1/es not_active Application Discontinuation
- 2005-08-12 AR ARP050103403A patent/AR050603A1/es unknown
- 2005-08-15 TW TW094127668A patent/TW200621780A/zh unknown
- 2005-08-15 TW TW094127669A patent/TW200621781A/zh unknown
- 2005-08-15 PE PE2005000948A patent/PE20060626A1/es not_active Application Discontinuation
- 2005-08-15 PE PE2005000947A patent/PE20060497A1/es not_active Application Discontinuation
- 2005-08-15 MY MYPI20053813A patent/MY145133A/en unknown
- 2005-08-16 DK DK05792575T patent/DK1781656T3/da active
- 2005-08-16 AT AT05792575T patent/ATE381564T1/de active
- 2005-08-16 BR BRPI0514404-3A patent/BRPI0514404A/pt not_active IP Right Cessation
- 2005-08-16 CN CN2005800279485A patent/CN101006091B/zh not_active Expired - Fee Related
- 2005-08-16 WO PCT/EP2005/008889 patent/WO2006018280A2/de active Application Filing
- 2005-08-16 AU AU2005274315A patent/AU2005274315A1/en not_active Abandoned
- 2005-08-16 SI SI200530140T patent/SI1781656T1/sl unknown
- 2005-08-16 KR KR1020077003920A patent/KR20070053225A/ko not_active Application Discontinuation
- 2005-08-16 RU RU2007109600/04A patent/RU2007109600A/ru not_active Application Discontinuation
- 2005-08-16 JP JP2007526380A patent/JP2008509957A/ja not_active Abandoned
- 2005-08-16 KR KR1020077003882A patent/KR20070046868A/ko not_active Application Discontinuation
- 2005-08-16 EP EP05792575A patent/EP1781656B1/de not_active Not-in-force
- 2005-08-16 CA CA002577255A patent/CA2577255A1/en not_active Abandoned
- 2005-08-16 CA CA002577261A patent/CA2577261A1/en not_active Abandoned
- 2005-08-16 ES ES05792575T patent/ES2297758T3/es active Active
- 2005-08-16 PT PT05792575T patent/PT1781656E/pt unknown
- 2005-08-16 MX MX2007001478A patent/MX2007001478A/es active IP Right Grant
- 2005-08-16 AU AU2005274314A patent/AU2005274314A1/en not_active Abandoned
- 2005-08-16 PL PL05792575T patent/PL1781656T3/pl unknown
- 2005-08-16 BR BRPI0514365-9A patent/BRPI0514365A/pt not_active IP Right Cessation
- 2005-08-16 UY UY29072A patent/UY29072A1/es unknown
- 2005-08-16 WO PCT/EP2005/008888 patent/WO2006018279A2/de active IP Right Grant
- 2005-08-16 DE DE502005002316T patent/DE502005002316D1/de active Active
- 2005-08-16 EP EP05777343.4A patent/EP1781663B1/de active Active
- 2005-08-16 MX MX2007001584A patent/MX2007001584A/es active IP Right Grant
- 2005-08-16 JP JP2007526381A patent/JP2008509958A/ja not_active Abandoned
- 2005-08-16 UY UY29071A patent/UY29071A1/es unknown
- 2005-08-16 CN CNA2005800279150A patent/CN101006089A/zh active Pending
2007
- 2007-01-12 ZA ZA200700354A patent/ZA200700354B/en unknown
- 2007-01-28 IL IL181008A patent/IL181008A0/en unknown
- 2007-01-28 IL IL181007A patent/IL181007A0/en unknown
- 2007-02-08 MA MA29673A patent/MA28795B1/fr unknown
- 2007-02-13 US US11/674,353 patent/US7838547B2/en not_active Expired - Fee Related
- 2007-02-16 US US11/675,646 patent/US7569583B2/en not_active Expired - Fee Related
- 2007-03-08 NO NO20071271A patent/NO20071271L/no not_active Application Discontinuation
2008
- 2008-02-18 CY CY20081100196T patent/CY1108077T1/el unknown
2009
- 2009-06-23 US US12/489,653 patent/US8357686B2/en not_active Expired - Fee Related
- 2009-06-23 US US12/489,648 patent/US8163741B2/en not_active Expired - Fee Related
2010
- 2010-07-29 US US12/846,075 patent/US8586609B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE502005002316D1 (de)	2008-01-31
US7569583B2 (en)	2009-08-04
AR050603A1 (es)	2006-11-08
DE102004039789A1 (de)	2006-03-02
TW200621780A (en)	2006-07-01
PE20060626A1 (es)	2006-08-08
CA2577255A1 (en)	2006-02-23
JP2008509958A (ja)	2008-04-03
US8163741B2 (en)	2012-04-24
MY145133A (en)	2011-12-30
CY1108077T1 (el)	2014-02-12
KR20070046868A (ko)	2007-05-03
WO2006018279A3 (de)	2006-05-11
MX2007001478A (es)	2007-04-19
UY29071A1 (es)	2006-03-31
US20070299077A1 (en)	2007-12-27
US20090258872A1 (en)	2009-10-15
RU2007109600A (ru)	2008-09-27
AR050604A1 (es)	2006-11-08
MA28795B1 (fr)	2007-08-01
MX2007001584A (es)	2007-04-20
WO2006018280A2 (de)	2006-02-23
IL181007A0 (en)	2007-07-04
PE20060497A1 (es)	2006-07-17
ZA200700354B (en)	2008-06-25
DK1781656T3 (da)	2008-05-05
US20070197584A1 (en)	2007-08-23
PT1781656E (pt)	2008-02-01
SI1781656T1 (sl)	2008-04-30
EP1781663A2 (de)	2007-05-09
EP1781663B1 (de)	2013-11-20
IL181008A0 (en)	2007-07-04
AU2005274315A1 (en)	2006-02-23
CN101006089A (zh)	2007-07-25
UY29072A1 (es)	2006-03-31
WO2006018279A2 (de)	2006-02-23
WO2006018280A3 (de)	2006-05-11
ATE381564T1 (de)	2008-01-15
BRPI0514365A (pt)	2008-06-10
EP1781656B1 (de)	2007-12-19
US8357686B2 (en)	2013-01-22
US20090258881A1 (en)	2009-10-15
CN101006091B (zh)	2010-09-15
ES2297758T3 (es)	2008-05-01
PL1781656T3 (pl)	2008-03-31
BRPI0514404A (pt)	2008-06-10
US20100298378A1 (en)	2010-11-25
JP2008509957A (ja)	2008-04-03
US7838547B2 (en)	2010-11-23
CA2577261A1 (en)	2006-02-23
TW200621781A (en)	2006-07-01
CN101006091A (zh)	2007-07-25
EP1781656A2 (de)	2007-05-09
US8586609B2 (en)	2013-11-19
KR20070053225A (ko)	2007-05-23
AU2005274314A1 (en)	2006-02-23

Publication	Publication Date	Title
NO20071271L (no)	2007-03-16	Aryl-substituerte polyakryliske aminer, fremgangsmate for fremstilling av disse og anvendelse som et medikament.
CY1120741T1 (el)	2019-12-11	Θεραπεια οζωδους σκληρυνσης
WO2007015017A3 (fr)	2007-05-10	Nouveaux derives de polyquinoleines et leur utilisation therapeutique
SG148192A1 (en)	2008-12-31	Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents
EP2023926A4 (en)	2010-08-04	PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS
UA102858C2 (ru)	2013-08-27	Производные пиридино-пиридинонов, способ их получения и применения в терапии
WO2007112014A3 (en)	2007-12-21	New therapeutic combinations for the treatment of depression
IL180551A0 (en)	2008-03-20	Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
GB0426313D0 (en)	2005-01-05	Therapeutic agents
NO20092690L (no)	2009-09-03	Aminderivater og deres anvendelse i beta-2-adrenoreseptormedierte sykdommer
MX2010006206A (es)	2011-03-04	Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
JO2682B1 (en)	2013-03-03	Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
MX2010009927A (es)	2010-09-30	Derivados de espiroindolinona.
DK2185561T3 (da)	2011-10-10	Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
MX2008002341A (es)	2008-03-18	Lavadora de platos, en particular una lavadora de platos con transportador.
NO20082838L (no)	2008-06-20	9-klor-15-deoksyprostaglandinderivater, fremgangsmate for fremstilling av disse, og anvendelse som medikamenter
NO20074528L (no)	2007-10-31	Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
SE0300457D0 (sv)	2003-02-19	Novel compounds
CY1109803T1 (el)	2014-09-10	Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση
CY1116166T1 (el)	2017-02-08	Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori
MX2008010804A (es)	2008-10-31	Derivados de rapamicina para tratar neuroblastoma.
NO20091386L (no)	2009-05-06	Fenyloksyanilinderivater
PA8646301A1 (es)	2006-09-08	Inhibidores de la adenilato ciclasa soluble
NO20045437L (no)	2004-12-13	Medikamenter for behandling av akutte dysfunksjoner i portavenesirkulasjon og hepatisk sirkulasjon
NO20085189L (no)	2009-02-11	2-alkoksy-3,4,5-trihydroksy-alkylamid-benzotaizepiner, fremstilling og anvendelse derav sammensetninger inneholdende samme

Legal Events

Date	Code	Title	Description
2012-03-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application